Regen BioPharma, Inc.
RGBP
$0.0548
$0.00479.38%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -929.80K | -1.03M | -662.40K | -722.50K | -691.60K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 45.50K | 37.20K | 29.00K | 13.90K | 9.60K |
| Total Other Non-Cash Items | 159.60K | 159.60K | 154.40K | 252.30K | 250.00K |
| Change in Net Operating Assets | 235.60K | 238.90K | -214.10K | -111.30K | -50.00K |
| Cash from Operations | -489.10K | -597.20K | -693.10K | -567.60K | -482.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 187.80K | 84.90K | 19.10K | 143.80K | 143.80K |
| Total Debt Repaid | 61.50K | 36.50K | -10.00K | -50.50K | -71.50K |
| Issuance of Common Stock | 163.40K | 351.30K | 563.60K | 535.50K | 400.20K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 412.80K | 472.80K | 572.80K | 628.80K | 472.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -76.40K | -124.40K | -120.30K | 61.10K | -9.60K |